AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2012
Feb 7, 2012
33431_dirs_2012-02-07_fd4f86f6-dfcf-4c11-97c9-2d2108afaebb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-02-03
Reporting Person: STEELE GARY T (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-03 | Common Stock | S | 4749 | $6.5097 | Disposed | 240535 | Indirect |
| 2012-02-06 | Common Stock | S | 1500 | $6.50270 | Disposed | 239035 | Indirect |
| 2012-02-07 | Common Stock | S | 18033 | $6.5532 | Disposed | 221002 | Indirect |
Footnotes
F1: All shares reported sold on this form 4 were sold pursuant to a 10b5-1 trading program.
More from LIFECORE BIOMEDICAL, INC. \DE\
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17
Regulatory Filings
2025
Oct 1